Tag: Tumor microenvironment
CytomX Therapeutics Acquires Technologies Developed by Agensys
Clinical-stage and oncology-focused biopharmaceutical company CytomX Therapeutics, pioneering a novel class of investigational antibody therapeutics based on its Probody™ therapeutic technology platform, has acquired...
Cutting-Edge Science: Personalized Drug Screening for Multiple Myeloma
In the decades old "war" against cancer, scientist are increasingly developing ore and better ways to help doctors address the unmet medical needs of...